XML 42 R40.htm IDEA: XBRL DOCUMENT v2.4.1.9
Share-based Compensation (Tables)
9 Months Ended
Mar. 31, 2015
Share-based Compensation  
Schedule of weighted average assumptions used to estimate fair values of the stock options granted and the estimated annual forfeiture rates used to recognize the associated compensation expense

 

 

March 31, 2015

 

March 31, 2014

 

Risk-free interest rate

 

1.7 

%

2.1 

%

Expected volatility

 

52.1 

%

62.9 

%

Expected dividend yield

 

0.0 

%

0.0 

%

Forfeiture rate

 

6.5 

%

7.5 

%

Expected term (in years)

 

5.5 years

 

5.9 years

 

Weighted average fair value

 

$

17.67 

 

$

8.14 

 

 

Summary of stock option award activity

(In thousands, except for weighted average price and life data)

 

Awards

 

Weighted-
Average
Exercise
Price

 

Aggregate
Intrinsic
Value

 

Weighted
Average
Remaining
Contractual
Life (yrs.)

 

 

 

 

 

 

 

 

 

 

 

Outstanding at July 1, 2014

 

2,205

 

$

7.84

 

 

 

 

 

Granted

 

509

 

$

36.55

 

 

 

 

 

Exercised

 

(541

)

$

6.78

 

$

26,800

 

 

 

Forfeited, expired or repurchased

 

(73

)

$

17.82

 

 

 

 

 

Outstanding at March 31, 2015

 

2,100

 

$

14.73

 

$

111,267

 

7.3

 

 

 

 

 

 

 

 

 

 

 

Vested and expected to vest at March 31, 2015

 

2,017

 

$

14.29

 

$

107,723

 

7.2

 

Exercisable at March 31, 2015

 

975

 

$

5.84

 

$

60,354

 

5.7

 

 

Summary of nonvested restricted stock awards

(In thousands)

 

Awards

 

Weighted
Average Grant -
date Fair Value

 

Aggregate
Intrinsic Value

 

 

 

 

 

 

 

 

 

Non-vested at July 1, 2014

 

15

 

34.66

 

 

 

Granted

 

103

 

37.97

 

 

 

Vested

 

(9

)

36.77

 

$

345

 

Forfeited

 

(5

)

36.55

 

 

 

Non-vested at March 31, 2015

 

104

 

$

37.68

 

 

 

 

Schedule of allocation of share-based compensation costs recognized in the Consolidated Statements of Operations by financial statement line item

 

 

Three Months Ended

 

Nine Months Ended

 

 

 

March 31,

 

March 31,

 

(In thousands)

 

2015

 

2014

 

2015

 

2014

 

Selling, general and administrative

 

$

1,195 

 

$

2,240 

 

$

3,805 

 

$

4,763 

 

Research and development

 

133 

 

225 

 

390 

 

443 

 

Cost of sales

 

182 

 

324 

 

534 

 

627 

 

Total

 

1,510 

 

2,789 

 

4,729 

 

5,833 

 

 

 

 

 

 

 

 

 

 

 

Tax benefit at statutory rate

 

$

514 

 

$

1,053 

 

$

1,589 

 

$

2,160